Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Anabolic steroid users may face higher risk of severe COVID-19.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Copper deficiency is linked to post-COVID-19 hair loss in women.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

Many COVID-19 survivors experience long-lasting symptoms, including hair loss and psychological issues.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Long COVID is more common in those with severe initial infections, but not linked to blood group.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Finasteride and dutasteride can cause severe, lasting side effects.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

Men with urinary symptoms are more likely to have erectile dysfunction, and there's a debate about research methods and authorship ethics.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Lipedema is a painful fat disorder in women that's hard to treat, often worsens with hormonal changes, and requires symptom-focused therapies.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.